Combating viruses isn’t simple: the COVID-19 pandemic has made that clear. As the virus began taking lives and occupying headlines, NC State scientists across several disciplines came together to explore creative strategies to combat viral infections.
Despite being in different parts of the university, they were able to start this important work quickly because of connections they formed as part of NC State’s Comparative Medicine Institute (CMI). This research institute encourages interdisciplinary collaborations among more than 200 biomedical sciences-focused researchers in six colleges and 26 academic departments at NC State, as well as researchers from UNC-Chapel Hill, Duke University and N.C. Central University.
Scientists in the institute use a team science approach, working together to study a broad range of problems related to human and animal health from the basic molecular level all the way through human and veterinary clinical trials.
“We have exactly the kinds of resources in sciences and veterinary medicine that help us solve problems that are relevant for human health,” says Joshua Pierce, CMI co-director and LORD Corporation Distinguished Scholar in the College of Sciences.
“Our program is the link between what happens at NC State in translational medicine, which uses basic science to investigate new medical therapies or procedures, and the clinical application at UNC and Duke,” says Jorge Piedrahita, CMI co-director and Randall B. Terry Jr. Distinguished Professor of Translational Medicine and Alumni Association Distinguished Graduate Professor in the College of Veterinary Medicine.